Literature DB >> 2738938

Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

K D Paull1, R H Shoemaker, L Hodes, A Monks, D A Scudiero, L Rubinstein, J Plowman, M R Boyd.   

Abstract

The objective of this study was to develop and investigate an approach to optimally detect, rank, display, and analyze patterns of differential growth inhibition among cultured cell lines. Such patterns of cellular responsiveness are produced by substances tested in vitro against disease-oriented panels of human tumor cell lines in a new anticancer screening model under development by the National Cancer Institute. In the first phase of the study, we developed a key methodological tool, the mean graph, which allowed the transformation of the numerical cell line response data into graphic patterns. These patterns were particularly expressive of differential cell growth inhibition and were conveniently amenable to further analyses by an algorithm we devised and implemented in the COMPARE computer program.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2738938     DOI: 10.1093/jnci/81.14.1088

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  205 in total

Review 1.  The complexity of radiation stress responses: analysis by informatics and functional genomics approaches.

Authors:  A J Fornace; S A Amundson; M Bittner; T G Myers; P Meltzer; J N Weinsten; J Trent
Journal:  Gene Expr       Date:  1999

2.  Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation.

Authors:  Nuha Mahmoud; Mohamed E M Saeed; Yoshikazu Sugimoto; Sabine M Klauck; Henry J Greten; Thomas Efferth
Journal:  Oncotarget       Date:  2018-11-06

3.  Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles.

Authors:  Jenny Chan; Shakila N Khan; Isabelle Harvey; William Merrick; Jerry Pelletier
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

Review 4.  ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system.

Authors:  De-xin Kong; Takao Yamori
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

5.  Predicting in vitro drug sensitivity using Random Forests.

Authors:  Gregory Riddick; Hua Song; Susie Ahn; Jennifer Walling; Diego Borges-Rivera; Wei Zhang; Howard A Fine
Journal:  Bioinformatics       Date:  2010-12-05       Impact factor: 6.937

6.  Antiproliferative mechanisms of action of the flavin dehydrogenase inhibitors diphenylene iodonium and di-2-thienyliodonium based on molecular profiling of the NCI-60 human tumor cell panel.

Authors:  James H Doroshow; Agnes Juhasz; Yun Ge; Susan Holbeck; Jiamo Lu; Smitha Antony; Yongzhong Wu; Guojian Jiang; Krishnendu Roy
Journal:  Biochem Pharmacol       Date:  2012-01-24       Impact factor: 5.858

7.  Fluorescent schweinfurthin B and F analogs with anti-proliferative activity.

Authors:  Joseph J Topczewski; Craig H Kuder; Jeffrey D Neighbors; Raymond J Hohl; David F Wiemer
Journal:  Bioorg Med Chem       Date:  2010-07-29       Impact factor: 3.641

8.  Improved Antitumor Activity of the Fluoropyrimidine Polymer CF10 in Preclinical Colorectal Cancer Models through Distinct Mechanistic and Pharmacologic Properties.

Authors:  William H Gmeiner; Anthony Dominijanni; Alex O Haber; Lais P Ghiraldeli; David L Caudell; Ralph D'Agostino; Boris C Pasche; Thomas L Smith; Zhiyong Deng; Sezgin Kiren; Chinnadurai Mani; Komaraiah Palle; Jonathan R Brody
Journal:  Mol Cancer Ther       Date:  2020-12-23       Impact factor: 6.261

9.  N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell lines.

Authors:  Jonathan A Stefely; Rahul Palchaudhuri; Patricia A Miller; Rebecca J Peterson; Garrett C Moraski; Paul J Hergenrother; Marvin J Miller
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

Review 10.  Integrating phenotypic small-molecule profiling and human genetics: the next phase in drug discovery.

Authors:  Cory M Johannessen; Paul A Clemons; Bridget K Wagner
Journal:  Trends Genet       Date:  2014-12-12       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.